Cargando…
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Glioma represents a fast proliferating and highly invasive brain tumor which is resistant to current therapies and invariably recurs. Despite some advancements in anti-glioma therapies, patients’ prognosis remains poor. Toll-like receptors (TLRs) act as the first line of defense in the immune system...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555307/ https://www.ncbi.nlm.nih.gov/pubmed/34715891 http://dx.doi.org/10.1186/s13045-021-01191-2 |